AzPA Pharmacy Flash
Mar. 18, 2015

2015 AzPA Annual Convention OPEN FOR REGISTRATION
Join us for three days of continuing education and networking June 26-28 at the Westin La Paloma Resort & Spa in Tucson. Choose to attend the full conference or specify a single day. AzPA members receive a reduced rate. Not a member? Don't worry. Your three-day Convention rate includes one year AzPA membership. Register now at More

New: APhA Cardiovascular Disease Risk Management June 25
The Arizona Pharmacy Association is offering APhA's Cardiovascular Disease Certificate Program this June. It's brand new! This program is the first step for pharmacists interested in learning the essential skills to successfully assess risk, promote cardiovascular disease prevention and encourage patient adherence to therapy. Join us in Tucson at the Westin La Paloma. Register here. More

Survey request: Vision Health Care
Six students at the New England College of Optometry in Boston are reaching out to pharmacists across the country. They have written a short survey for a course called Vision Health Care hoping to get an idea of how often patients approach pharmacists with questions about their eyes or their vision, and how those questions are answered. The survey is very short — it should only take five minutes of your time — and participants will remain completely anonymous. Please consider helping these by completing the survey by March 20. The results of the survey will be compiled and presented in poster form at our Public Health Presentation Day in April. Complete the survey here. More

Save $50: AzPA Women's Reproductive Health Certificate Program
Register before March 30 and save $50 with early bird pricing. Join us April 25 in Phoenix to discuss the management and care of commonly encountered female reproductive issues such as contraception, menstrual disorders, infertility and pregnancy. Register at! More

History proves community pharmacy is far from extinction
By Greg L. Alston
I read with great interest a recent blog post titled, "Is community pharmacy a dying profession?" While the article laments the loss of control of our profession to third-party actors, the storm of responses is even more telling. The passion raised by multiple respondents calls for everything from the development of a national union to altering the underlying economics of the drug industry. One of the benefits of having gray hair is that I have lived long enough to see this same question asked for 40-plus years, and the angst level generated in 1977 is not much different from what pharmacists are feeling now.More

Andexanet alfa reverses blood thinning of rivaroxaban
Full results from a Phase III study examining Portola Pharmaceutical's developmental compound andexanet alfa found it rapidly and significantly reversed the anticoagulant effects of rivaroxaban. These results will be presented at the American College of Cardiology meeting March 16.More

New survey shows Americans prefer education over restricted access when it comes to OTC pain medications
Medical News Today
A new survey of 1,600 Americans ages 18 and over found that adults overwhelmingly prefer education about the safe use of over-the-counter medications, particularly those containing acetaminophen, and disagree with restricting access to those same OTC medications as the alternative.More

DEA contributes to shortages of drugs with controlled substances
A new report from the U.S. Government Accountability Office finds DEA has contributed to a noticeable shortage of prescription drugs containing controlled substances, such as narcotics and stimulants, causing difficulties for both patients and physicians.More

Effective drug therapy for Alzheimer's disease remains elusive
In the two years since the United States set a national goal of effectively preventing or treating Alzheimer's disease by 2025, no new therapies have been approved, and recent clinical trials of investigational drugs have proved disappointing. More

Doctors establishing pharmacies inside practices to make patients' lives easier
Gainesville Times
As more consumers seem to favor one-stop shopping with their retail choices, some doctors’ offices are starting to adopt the same trend by establishing pharmacies inside their own practices. A pharmacy inside a doctor’s office proves advantageous for patients and relief for doctors.More

FDA leans on another compound pharmacy for manufacturing problems
The Wall Street Journal
Once again, the FDA has taken a tough stance against a compound pharmacy with quality-control problems that led to product recalls and concerns over patient safety. In this latest instance, the agency obtained a consent decree that prohibits Specialty Compounding from making or distributing injectable sterile medicines until the company complies with federal law governing manufacturing practices.More

Pharmacist forfeits $2 million for filling illegal Fioricet orders
Pharmacy Times
Following accusations of conspiracy, a Mississippi pharmacist will pay the federal government $2 million as part of a plea deal. More

Prepare now for USP standard on handling hazardous drugs
No one knows exactly when healthcare facilities will be required to meet the requirements for handling hazardous drugs specified in United States Pharmacopeia chapter 800. But now is the time to plan for compliance with the chapter, said Patricia C. Kienle, director of accreditation and medication safety for Cardinal Health Innovative Delivery Solutions. More